 While it is difficult to predict what the rest of 2020 will look like, we are starting to see orders come in as our customers re-open and we continue to be excited about Harrows upcoming events, catalysts, and developments in the near and long-term. The Company also owns royalty rights in certain drug candidates being developed by Surface, Melt, Mayfield and Radley. 